03/27/2024 6:01 AM | Nurix Therapeutics (Filer)
| Form DEF 14A | |
03/27/2024 6:02 AM | Nurix Therapeutics (Filer)
| Form DEFA14A | |
03/27/2024 6:03 AM | Nurix Therapeutics (Filer)
| Form ARS | |
03/11/2024 6:02 AM | Nurix Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/16/2024 6:20 PM | Nurix Therapeutics (Issuer) van Houte Hans (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 3:22 PM | Nurix Therapeutics (Subject) van Houte Hans (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/15/2024 3:51 PM | Nurix Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
|
02/15/2024 6:22 AM | Nurix Therapeutics (Issuer) SANDS ARTHUR T (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 6:23 AM | Hansen Gwenn (Reporting) Nurix Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 6:23 AM | Nurix Therapeutics (Issuer) Ring Christine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 6:23 AM | Nurix Therapeutics (Issuer) van Houte Hans (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 7:51 AM | Deep Track Capital, LP (Filed by) Nurix Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024 7:00 AM | Nurix Therapeutics (Subject) SANDS ARTHUR T (Filed by)
| Form SC 13G | |
02/09/2024 12:47 PM | MORGAN STANLEY (Filed by) Nurix Therapeutics (Subject)
| Form SC 13G | |
02/09/2024 12:56 PM | Nurix Therapeutics (Subject) WASATCH ADVISORS LP (Filed by)
| Form SC 13G/A | |
01/30/2024 5:52 PM | Nurix Therapeutics (Issuer) Ring Christine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/30/2024 5:52 PM | Hansen Gwenn (Reporting) Nurix Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/30/2024 5:53 PM | Nurix Therapeutics (Issuer) van Houte Hans (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/29/2024 3:00 PM | ARK Investment Management LLC (Filed by) Nurix Therapeutics (Subject)
| Form SC 13G | |
01/24/2024 1:27 PM | BlackRock Inc. (Filed by) Nurix Therapeutics (Subject)
| Form SC 13G/A | |
01/23/2024 9:28 AM | Nurix Therapeutics (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/08/2024 6:03 AM | Nurix Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/21/2023 4:19 PM | Nurix Therapeutics (Issuer) van Houte Hans (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 3:55 PM | Nurix Therapeutics (Issuer) van Houte Hans (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 11:03 AM | Nurix Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/13/2023 6:01 AM | Nurix Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/01/2023 3:40 PM | Hansen Gwenn (Reporting) Nurix Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/01/2023 3:40 PM | Nurix Therapeutics (Issuer) Ring Christine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/01/2023 3:41 PM | Nurix Therapeutics (Issuer) van Houte Hans (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/12/2023 3:03 PM | Nurix Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/12/2023 3:06 PM | Nurix Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
09/07/2023 6:02 AM | Nurix Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/01/2023 3:26 PM | Hansen Gwenn (Reporting) Nurix Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/01/2023 3:27 PM | Nurix Therapeutics (Issuer) Ring Christine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/01/2023 3:28 PM | Nurix Therapeutics (Issuer) van Houte Hans (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/13/2023 3:18 PM | Nurix Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/13/2023 3:19 PM | Nurix Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/04/2023 6:56 PM | Kunkel Lori Anne (Reporting) Nurix Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/04/2023 6:57 PM | Lacey David L. (Reporting) Nurix Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/04/2023 6:58 PM | Nurix Therapeutics (Issuer) Reinsdorf Judith A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/04/2023 6:58 PM | Nurix Therapeutics (Issuer) Saltzman Edward C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
AI healthcare stock poised for 36,996% growth? (Ad) Buy Alert Issued For AI Small Cap
Our last two AI stocks jumped 150% and 130%...
But we just issued a brand new "buy alert" for a new one... Get the name of the stock here... |
05/04/2023 7:00 PM | Nurix Therapeutics (Issuer) Silva Paul M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/04/2023 6:55 PM | GREGORY JULIA P (Reporting) Nurix Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/04/2023 3:09 PM | Nurix Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/02/2023 3:31 PM | Hansen Gwenn (Reporting) Nurix Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/02/2023 3:32 PM | Nurix Therapeutics (Issuer) Ring Christine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/10/2023 6:16 AM | Nurix Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/06/2023 11:15 PM | Nurix Therapeutics (Filer)
| Form EFFECT | |